Identification and functional characterization of a missense mutation in resistin in two patients with severe obesity and insulin resistance.

OBJECTIVE In this study, we hypothesized that mutations in the resistin encoding gene, RETN, may cause a monogenic form of obesity. DESIGN/METHODS We screened the coding region of RETN in 81 morbidly obese adults, 263 overweight and obese children/adolescents, and 116 healthy lean subjects. In vitro experiments include qPCR, ELISA, and western blot for WT and mutant resistin transfected into 3T3-L1 adipocytes. RESULTS Mutation analysis identified five sequence variants in our patient populations: 3'-UTR +87 G/A, 3'-UTR +100 A/G, T73T, IV3-61 C/A, and C78S. In our control population, we only found the 3'-UTR +87 G/A variant. We started functional experiments for the C78S mutation that was found in a 20-year-old obese male (body mass index (BMI)=39.7 kg/m(2)) and his obese mother (BMI=31.9 kg/m(2)). In vitro testing demonstrated that the mutation does not impair mRNA expression. We identified a 100-fold lower extracellular protein concentration for mutant resistin compared with WT levels using a resistin ELISA on cell culture medium (P=4.87×10(-6)). We also detected a decreased intracellular concentration for the mutant protein (tenfold lower relative levels, P=0.007). The plasma resistin levels of the proband and his mother, however, did not differ significantly from lean control individuals. CONCLUSIONS In conclusion, we identified the first missense mutation in resistin in a morbidly obese proband and his obese mother. Functional testing of the mutant protein suggests that the C78S mutant protein is degraded, possibly resulting in a decreased extracellular concentration, which may predispose to obesity.

[1]  K. Kohara,et al.  A at Single Nucleotide Polymorphism-358 Is Required for G at -420 to Confer the Highest Plasma Resistin in the General Japanese Population , 2010, PloS one.

[2]  M. Roelants,et al.  References for growth and pubertal development from birth to 21 years in Flanders, Belgium , 2009, Annals of human biology.

[3]  M. Matoulek,et al.  The use of microdialysis to characterize the endocrine production of human subcutaneous adipose tissue in vivo , 2009, Regulatory Peptides.

[4]  C. Fox,et al.  Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study , 2009, Diabetes.

[5]  R. Ahima,et al.  Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. , 2008, American Journal of Physiology. Endocrinology and Metabolism.

[6]  W. Hul,et al.  Analysis of Genetic Variations in the Resistin Gene Shows No Associations With Obesity in Women , 2008, Obesity.

[7]  P. Kleiblova,et al.  Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression , 2007, Clinical endocrinology.

[8]  G. Mortier,et al.  qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data , 2007, Genome Biology.

[9]  U. Smith,et al.  Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes , 2006, PloS one.

[10]  M. Lazar,et al.  Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency , 2006, Diabetes.

[11]  J. Dušková,et al.  Adipose tissue resistin levels in patients with anorexia nervosa. , 2006, Nutrition.

[12]  W. Hul,et al.  Screening for melanocortin-4 receptor mutations in a cohort of Belgian morbidly obese adults and children , 2006, International Journal of Obesity.

[13]  J. Kratzsch,et al.  Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. , 2006, Journal of internal medicine.

[14]  J. Kratzsch,et al.  Resistin gene 3′‐untranslated region +62G→A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population , 2005 .

[15]  Anil Kumar Singh,et al.  Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. , 2005, Biochemical and biophysical research communications.

[16]  F. Vesuna,et al.  Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. , 2005, Analytical biochemistry.

[17]  Xi-rong Guo,et al.  A mutation in signal peptide of rat resistin gene inhibits differentiation of 3T3-L1 preadipocytes. , 2004, Acta pharmacologica Sinica.

[18]  M. Reilly,et al.  An Inflammatory Cascade Leading to Hyperresistinemia in Humans , 2004, PLoS medicine.

[19]  J. Olefsky,et al.  Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. , 2004, The Journal of clinical investigation.

[20]  B. Monia,et al.  Role of resistin in diet-induced hepatic insulin resistance. , 2004, The Journal of clinical investigation.

[21]  Philipp E. Scherer,et al.  Disulfide-Dependent Multimeric Assembly of Resistin Family Hormones , 2004, Science.

[22]  H. Sul,et al.  Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Lazar,et al.  The current biology of resistin , 2004, Journal of internal medicine.

[24]  M. Lazar,et al.  Regulation of Fasted Blood Glucose by Resistin , 2004, Science.

[25]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[26]  Y. M. Cho,et al.  Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans , 2004, Diabetologia.

[27]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[28]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[29]  R. Considine,et al.  Serum resistin (FIZZ3) protein is increased in obese humans. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  P. Sucharda,et al.  Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. , 2003, European journal of endocrinology.

[31]  J. Chan,et al.  Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[32]  T. Saruta,et al.  Correlation between serum resistin level and adiposity in obese individuals. , 2003, Obesity research.

[33]  Steven R Smith,et al.  A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. , 2003, Diabetes.

[34]  S. Bahouth,et al.  Resistin release by human adipose tissue explants in primary culture. , 2003, Biochemical and biophysical research communications.

[35]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[36]  P. Murdock,et al.  Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. , 2003, Biochemical and biophysical research communications.

[37]  A. Doria,et al.  Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. , 2002, The Journal of clinical endocrinology and metabolism.

[38]  B. Dallapiccola,et al.  An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[39]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[40]  Scott M. Williams,et al.  5' flanking variants of resistin are associated with obesity. , 2002, Diabetes.

[41]  M. Arca,et al.  Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. , 2002, Diabetes.

[42]  H. Sul,et al.  A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation* , 2001, The Journal of Biological Chemistry.

[43]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[44]  F. Peale,et al.  FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.

[45]  N. Golden,et al.  in Women with , 1992 .

[46]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.